J. Raker

InCVAX as a Novel In Situ Autologous Cancer Vaccine

Wei R. Chen, R. Nordquist, T. Hode, 2015 .

N-dihydrogalactochitosan as a potent immune activator for dendritic cells.

Michael R Hamblin, Wei R. Chen, M. Hamblin, 2017, Journal of biomedical materials research. Part A.

InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity.

Wei R. Chen, R. Nordquist, M. Naylor, 2015, Cancer letters.

Laser immunotherapy for advanced solid tumors

Feifan Zhou, Wei R. Chen, Mark F. Naylor, 2017, BiOS.

N‐Dihydrogalactochitosan Drives Conventional and Alternative Activations of STING to Synergize Type I IFN and IL‐1β Productions for Antitumor Immunity.

Trisha I. Valerio, T. Hode, Kaili Liu, 2024, Advanced Functional Materials.